Skip to main content

Contineum Therapeutics, Inc 10-K for FY2024

Contineum Therapeutics, Inc. (CTNM)

10-K 2025-03-06 For: 2024-12-31
View Original
Added on April 09, 2026

About this 10-K

Contineum Therapeutics, Inc filed this 10-K on March 6, 2025, covering the fiscal year ended December 31, 2024 (FY2024).

Headline figures

Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$0
compared with $50M a year earlier
Net loss
$42.26M
compared with net income of $22.72M a year earlier
Diluted EPS
-$2.18
compared with $0.08 a year earlier